While biosimilars have gained traction in markets such as Europe and the United States, Canada’s progress has been cautious and comparatively slow. Despite the strong potential for cost savings and access expansion, a mix of regulatory, market, and policy challenges...
Montreal, QC. May 27, 2025 – The Pharmaceutical Sciences Group (PSG) and the Canadian Alliance for Skills and Training in Life Sciences (CASTL), today announced a partnership to jointly offer training programs for Canada’s life‑sciences sector. The partnership unites...
The post-COVID, AI-driven world has reshaped the pharmaceutical industry in numerous ways, transforming processes, regulations, and, most of all, career pathways. What once worked in pharmaceutical hiring and operations has evolved into a rapidly changing digital...
It’s a question echoing through boardrooms, chat threads, and lab floors across the industry. The recent explosion of tools like ChatGPT, IBM Watson, Co-Pilot, and DeepSeek has sparked excitement and anxiety, depending on who you ask. But as artificial intelligence...
This past fall, the University of Toronto Mississauga (UTM) proudly unveiled its new science building, a major milestone in sustainable infrastructure. Designed to meet the university’s highest performance standards, the facility stands as one of North America’s...
Recent Comments